Ticker,Title,Link
INCY,"Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print",9/6/2024 7:00:22 PM
INCY,Eli Lilly inks licensing deal to expand Olumiant access in Africa,9/4/2024 11:01:23 AM
INCY,RBC Capital Sticks to Their Hold Rating for Incyte (INCY),9/3/2024 12:16:10 PM
INCY,Incyte Corporation: Market Successes Counterbalanced by Valuation and Patent Expiry Concerns,8/19/2024 4:55:13 AM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cochlear Limited (OtherCHEOF),8/18/2024 3:50:23 PM
INCY,Incyte’s Niktimvo Faces Market Challenges Despite FDA Approval: Analyst Upholds Hold Rating,8/16/2024 8:17:30 AM
INCY,Incyte's Monjuvi meets primary endpoint in follicular lymphoma phase 3 trial,8/15/2024 9:13:57 PM
INCY,FDA approves Incyte's Niktimvo for chronic graft-versus-host disease,8/14/2024 8:18:23 PM
INCY,Incyte (INCY) Gets a Hold from Wells Fargo,8/12/2024 11:19:10 AM
INCY,Incyte Corporation: Revised Earnings and Cautious Hold Rating Amid Unforeseen Financial Commitment,8/7/2024 5:56:56 AM
INCY,Stifel Nicolaus Sticks to Their Hold Rating for Incyte (INCY),8/2/2024 2:06:46 AM
INCY,"Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Terns Pharmaceuticals (TERN) and Stryker (SYK)",8/1/2024 7:42:59 AM
INCY,Wall Street Analysts Are Neutral on Top Healthcare Picks,7/31/2024 12:30:34 PM
INCY,Incite’s Strong Q2 Performance and Growth Potential Affirm Buy Rating,7/30/2024 9:55:54 PM
INCY,Incyte Q2 2024 Earnings Preview,7/29/2024 5:40:34 PM
INCY,Most shorted S&P 500 stocks in June,7/17/2024 1:52:11 PM
INCY,"Incyte, Moderna among most shorted S&P 500 healthcare stocks in June",7/16/2024 5:01:00 PM
INCY,"S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?",7/9/2024 7:47:11 PM
INCY,"Notable analyst calls this week: Nvidia, Spirit Airlines and PayPal among top picks",7/6/2024 6:31:00 PM
INCY,3 Highly Rated Biotech Stocks for Your July Buy List,7/5/2024 10:20:00 AM
INCY,This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday,7/2/2024 7:32:46 PM
INCY,7 Undervalued Biotech Stocks to Buy for Big-Time Returns,7/1/2024 6:18:31 PM
INCY,Analyst Expectations For Incyte's Future,6/18/2024 4:01:02 PM
INCY,"Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers",6/13/2024 10:38:57 PM
INCY,Incyte tenders ~29.8M shares at $60.00 per share,6/11/2024 1:11:12 PM
INCY,Incyte Corporation: A Hold Rating Amidst Clinical Data and Financial Decisions,6/5/2024 6:55:21 PM
INCY,TD Cowen Sticks to Their Buy Rating for Incyte (INCY),6/4/2024 11:35:07 AM
INCY,Incyte a new hold at Deutsche Bank as key drugs approach patent cliffs,5/23/2024 4:43:05 PM
INCY,Incyte’s Share Buyback Program: A Buy Rating and Fundamental Value Increase,5/16/2024 8:07:29 AM
INCY,Incyte’s Strategic Financial Decisions and Market Positioning: A Hold Rating Analysis,5/13/2024 10:46:49 PM
INCY,"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Incyte (INCY) and Ventyx Biosciences (VTYX)",5/10/2024 11:30:48 AM
INCY,The 3 Best Biotech Stocks to Buy in May 2024,5/9/2024 10:15:00 AM
INCY,Incyte’s Resilient Demand and Strong Financials Justify Buy Rating Despite Q1 Sales Dip,5/2/2024 6:16:16 AM
INCY,"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), TransMedics Group (TMDX) and Incyte (INCY)",5/1/2024 12:01:07 PM
INCY,"INCY Stock Earnings: Incyte Misses EPS, Misses Revenue for Q1 2024",4/30/2024 3:54:39 PM
INCY,Incyte Q1 2024 Earnings Preview,4/29/2024 3:44:31 PM
INCY,Repare Therapeutics appoints Steven Stein to its board of directors,4/26/2024 8:18:41 PM
INCY,Oppenheimer Sticks to Its Buy Rating for Incyte (INCY),4/24/2024 11:46:17 AM
INCY,Incyte’s Strategic Acquisition: A Premature and Costly Move Amid Patent Cliff Concerns,4/23/2024 11:05:18 PM
INCY,Goldman picks top capex and R&D stocks,4/21/2024 6:42:04 PM
INCY,"Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)",4/9/2024 2:40:06 AM
INCY,Jury sides with SEC in trial over insider trading charges against former pharma executive,4/6/2024 3:54:38 PM
INCY,Top buy-rated stocks and sell-rated stocks within Health Care - Citi,4/4/2024 3:12:55 PM
INCY,"CMS To Receive License To Develop, Commercialize Povorcitinib In China And Southeast Asia ",4/1/2024 3:10:03 PM
INCY,RBC Capital Sticks to Its Hold Rating for Incyte (INCY),3/25/2024 1:48:12 AM
INCY,"Analysts Are Bullish on Top Healthcare Stocks: biote (BTMD), Incyte (INCY)",3/13/2024 11:40:59 AM
INCY,Incyte Stock: A Deep Dive Into Analyst Perspectives (8 Ratings),3/12/2024 5:00:56 PM
INCY,Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead,3/11/2024 5:02:02 PM
INCY,3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise,3/7/2024 8:00:00 PM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Insmed (INSM),3/5/2024 12:40:18 PM
INCY,Knight Therapeutics launches Minjuvi in Brazil,2/29/2024 12:59:36 PM
INCY,Incyte's Axatilimab Receives FDA Priority Review For Chronic Graft-Versus-Host Disease Treatment ,2/28/2024 3:25:42 AM
INCY,FDA accepts Incyte application for graft-versus-host disease drug,2/27/2024 10:22:29 PM
INCY,7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff,2/26/2024 8:20:23 PM
INCY,Incyte a new Buy at Jefferies on prospects beyond Jakafi,2/23/2024 4:14:07 PM
INCY,Exit Now! 3 Biotech Stocks to Sell in February 2024,2/21/2024 9:50:00 PM
INCY,"Analysts Conflicted on These Healthcare Names: Incyte (INCY), Gilead Sciences (GILD) and Shockwave Medical (SWAV)",2/16/2024 1:00:33 PM
INCY,Incyte Corporation: A Hold Recommendation Amidst Modest Growth and Pipeline Developments,2/15/2024 7:55:20 AM
INCY,"JMP cuts Incyte to market perform, cites need for acquisition",2/14/2024 8:20:31 PM
INCY,Incyte’s Robust Market Potential and Financial Performance Prompt Buy Rating,2/13/2024 10:25:22 PM
INCY,Incyte Q4 2023 Earnings Preview,2/12/2024 4:41:12 PM
INCY,Incyte’s Hold Rating Affirmed Amid MONJUVI Acquisition and Novartis Competition,2/7/2024 3:35:49 PM
INCY,Incyte (INCY) Receives a Buy from Oppenheimer,2/6/2024 12:47:30 PM
INCY,Incyte buys global rights for tafasitamab from MorphoSys,2/5/2024 10:52:08 PM
INCY,"Agilent, Incyte To Collaborate On CDx Development Programs - Quick Facts ",1/30/2024 2:46:07 PM
INCY,Incyte Stock Maintains Hold Rating Amid Pipeline Risks and Patent Expiry Concerns,1/26/2024 5:46:57 AM
INCY,3 Pharma Stocks Could Be the Pills Your Portfolio Needs,1/18/2024 9:00:00 PM
INCY,"Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Incyte (INCY) and Nkarta (NKTX)",1/11/2024 6:31:39 AM
INCY,"Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations",1/10/2024 9:12:52 PM
INCY,Incyte’s Strong Outlook and Strategic Initiatives Warrant a Buy Rating,1/9/2024 11:28:42 AM
INCY,RBC Capital Remains a Hold on Incyte (INCY),1/6/2024 1:46:21 AM
INCY,Incyte’s Growth Prospects Bolstered by Axatilimab’s Advancements and Market Potential: A Strong Buy Rating,1/3/2024 12:05:44 AM
INCY,Wells Fargo Sticks to Their Hold Rating for Incyte (INCY),12/19/2023 12:26:38 PM
INCY,AI Meets Biotech: 3 Top Stocks Transforming Medical Science,12/16/2023 6:00:00 PM
INCY,The 3 Most Undervalued Biotech Stocks to Buy in December,12/15/2023 7:30:49 PM
INCY,Expert Ratings for Incyte,12/13/2023 4:00:24 PM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Pharming Group (PHAR),12/12/2023 1:02:28 PM
INCY,Incyte’s Promising Pipeline and Approaching Challenges: A Balanced Hold Rating,12/11/2023 12:17:34 PM
INCY,Incyte (INCY) Gets a Hold from Wells Fargo,12/1/2023 12:17:14 PM
INCY,"Analysts Offer Insights on Healthcare Companies: POINT Biopharma Global (PNT), Regeneron (REGN) and Incyte (INCY)",11/30/2023 2:30:21 AM
INCY,"Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness",11/21/2023 9:05:46 PM
INCY,"Analysts Are Bullish on Top Healthcare Stocks: Incyte (INCY), Royalty Pharma (RPRX)",11/14/2023 1:02:47 PM
INCY,3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024,11/12/2023 1:18:35 PM
INCY,7 Underappreciated Biotech Stocks to Pick Up on the Cheap,11/10/2023 3:01:38 AM
INCY,Incyte (INCY) Receives a Buy from Truist Financial,11/9/2023 2:28:11 AM
INCY,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amarin (AMRN), Protara Therapeutics (TARA) and Incyte (INCY)",11/6/2023 11:26:36 AM
INCY,Stifel Nicolaus Keeps Their Hold Rating on Incyte (INCY),11/3/2023 2:07:44 AM
INCY,Reni Benjamin Upholds Buy Rating on Incyte’s Stock Despite 3Q23 Financial Miss: Promising Dermatology Growth and Cash Position Drive Positive Outlook,11/2/2023 7:12:54 PM
INCY,Incyte’s Competitive Challenges and Potential Growth Drivers: A Hold Rating Perspective,11/1/2023 12:36:34 PM
INCY,TD Cowen Reaffirms Their Buy Rating on Incyte (INCY),10/31/2023 9:07:12 PM
INCY,Incyte is about to announce its earnings — here's what Wall Street expects,10/30/2023 3:01:13 PM
INCY,Oppenheimer Sticks to Their Buy Rating for Incyte (INCY),10/27/2023 12:06:39 PM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Fusion Pharmaceuticals (FUSN),10/12/2023 11:40:41 AM
INCY,RBC Capital Remains a Hold on Incyte (INCY),10/6/2023 1:46:39 AM
INCY,Quant Ratings Updated on 73 Stocks,9/26/2023 8:30:00 PM
INCY,Expert Ratings for Incyte,9/21/2023 9:00:30 PM
INCY,3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall,9/20/2023 6:15:34 PM
INCY,"Analysts’ Top Healthcare Picks: Aclaris Therapeutics (ACRS), Incyte (INCY)",9/19/2023 10:30:47 AM
INCY,Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison,9/18/2023 7:59:46 PM
INCY,"AbCellera, Incyte partner for antibody-based cancer drugs",9/13/2023 2:25:54 PM
INCY,Wells Fargo Sticks to Their Hold Rating for Incyte (INCY),9/11/2023 9:15:38 AM
INCY,BriaCell falls after Phase 2 data for lead asset in breast cancer,9/8/2023 7:09:33 PM
INCY,Incyte ends agreement with Syros on blood cancer treatments,8/11/2023 9:25:03 PM
INCY,Stocks most loved and shunned by hedge funds,8/6/2023 9:35:15 PM
INCY,Analyst Ratings for Incyte,8/2/2023 8:00:42 PM
INCY,"Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share",8/1/2023 10:31:03 PM
INCY,"Replimune, Incyte to collaborate on squamous cell carcinoma combo",7/31/2023 9:35:22 PM
INCY,"Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings",7/26/2023 4:39:46 AM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023",7/25/2023 5:00:40 PM
INCY,"Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End",7/24/2023 5:10:31 PM
INCY,"'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla",7/19/2023 2:44:18 PM
INCY,Karyopharm granted Fast Track designation for selinexor for myelofibrosis,7/17/2023 9:13:52 PM
INCY,Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape,7/11/2023 9:43:05 PM
INCY,Incyte wins U.K. approval for vitiligo cream Opzelura,7/5/2023 12:23:41 PM
INCY,Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent,6/29/2023 9:02:34 AM
INCY,Mizuho Securities Remains a Hold on Incyte (INCY),6/28/2023 8:55:12 PM
INCY,Goldman adds 25 new stocks with growth potential to its ROE basket,6/23/2023 8:59:05 AM
INCY,Xencor a buy at BofA on protein therapeutics,5/19/2023 3:27:29 PM
INCY,SVB Securities Sticks to Their Hold Rating for Incyte (INCY),5/5/2023 3:15:55 PM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023",5/4/2023 5:00:45 PM
INCY,Incyte (INCY) Gets a Hold from BMO Capital,5/3/2023 11:15:46 AM
INCY,Goldman Sachs Reaffirms Their Buy Rating on Incyte (INCY),5/2/2023 9:05:10 PM
INCY,Incyte earnings preview: what Wall Street is expecting,5/1/2023 3:01:13 PM
INCY,What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks,4/21/2023 9:06:37 PM
INCY,Incyte's Opzelura for vitiligo wins approval in EU,4/20/2023 3:32:46 PM
INCY,7 Biotech Stocks That Could Cure Your Portfolio Woes,4/19/2023 11:22:04 PM
INCY,"MorphoSys : Long-term Data Show Prolonged, Durable Responses In DLBCL Patients Treated With Monjuvi ",4/17/2023 3:53:11 AM
INCY,Ghana 1st in world to approve new malaria vaccine by Oxford,4/14/2023 9:32:00 AM
INCY,"Appeals court permits limited access to abortion pill, blocks part of Texas ruling",4/13/2023 9:02:47 AM
INCY,Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and COMPASS Pathways (CMPS),4/12/2023 4:40:47 PM
INCY,US DOJ asks appeals court to block Texas judge abortion pill ruling,4/11/2023 12:56:42 PM
INCY,"Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target",4/10/2023 5:25:00 PM
INCY,RBC Capital Sticks to Its Buy Rating for Incyte (INCY),4/8/2023 1:45:33 AM
INCY,MorphoSys adds 16% on faster timeline for Phase 3 myelofibrosis program,4/5/2023 3:58:46 PM
INCY,What 13 Analyst Ratings Have To Say About Incyte,3/28/2023 5:02:02 PM
INCY,Incyte wins Japanese approval for bone cancer therapy Pemazyre,3/27/2023 10:27:57 AM
INCY,Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets ,3/24/2023 11:52:29 AM
INCY,"Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval",3/23/2023 12:39:20 PM
INCY,Incyte (INCY) Receives a Hold from Mizuho Securities,3/22/2023 9:15:18 PM
INCY,7 Healthcare Stocks to Buy for Long-Term Growth and Stability,3/21/2023 8:13:55 PM
INCY,"Analyst Writes Incyte's Opzelura Provides Deepening, Relapse Prevention; Povo Data Intriguing In Depigmented Skin Disorder",3/20/2023 3:40:38 PM
INCY,Incyte (INCY) Receives a Hold from Mizuho Securities,3/19/2023 11:55:14 PM
INCY,"Catalyst watch: Spotlight on the Fed meeting, Nvidia, Nike And Foot Locker",3/17/2023 7:00:22 PM
INCY,"Catalyst watch: Microsoft ramps up AI talk, FedEx earnings and voting drama with AMC Entertainment & Ritchie Bros.",3/10/2023 8:00:56 PM
INCY,Incyte (INCY) Receives a Sell from SVB Securities,3/9/2023 4:05:47 AM
INCY,Sleep-at-night stocks for those hedging or risk averse,3/8/2023 11:41:29 AM
INCY,Analyst Expectations for Incyte's Future,3/7/2023 3:00:48 PM
INCY,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Incyte (INCY) and Seer (SEER)",3/6/2023 10:11:38 AM
INCY,Mizuho Securities Keeps Their Hold Rating on Incyte (INCY),3/3/2023 11:15:11 PM
INCY,Biotech Stocks Facing FDA Decision In March 2023 ,2/28/2023 9:45:54 AM
INCY,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Incyte (INCY) and Humana (HUM)",2/24/2023 4:20:10 PM
INCY,Don't give up on these stocks punished by earnings - Goldman,2/20/2023 7:23:47 AM
INCY,Concert retains breakthrough status for hair loss therapy despite rival entry,2/15/2023 6:54:20 PM
INCY,Wall Street Analysts Are Bullish on Top Healthcare Picks,2/13/2023 5:30:26 AM
INCY,Incyte skin disorder drug shows durable efficacy in 1 year data from mis-stage trial,2/10/2023 2:17:18 PM
INCY,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Neurocrine (NBIX) and Deciphera Pharmaceuticals (DCPH)",2/9/2023 2:10:20 AM
INCY,Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and Premier (PINC),2/8/2023 5:40:19 PM
INCY,Incyte down 5% following quarterly earnings as Street reacts to 2023 Jakafi estimates,2/7/2023 5:26:38 PM
INCY,JMP Securities Sticks to Its Buy Rating for Incyte (INCY),2/6/2023 4:25:14 PM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023",1/31/2023 4:00:32 PM
INCY,Global drug spending to reach $1.9T by 2027 – IQVIA,1/22/2023 5:00:19 PM
INCY,7 Biotech Stocks That Will Make You Rich in 10 Years,1/18/2023 8:44:49 PM
INCY,Incyte (INCY) Gets a Buy from RBC Capital,1/17/2023 1:45:36 AM
INCY,Goldman picks 50 top return-on-equity stocks for a tough ROE year,1/16/2023 3:23:03 PM
INCY,Mizuho Securities Sticks to Their Hold Rating for Incyte (INCY),1/11/2023 9:45:10 PM
INCY,Incyte (INCY) Gets a Buy from RBC Capital,1/7/2023 1:45:48 AM
INCY,Why These 7 Healthcare Stocks Could Soar in 2023,1/2/2023 12:22:52 PM
INCY,7 Undervalued Biotech Stocks to Buy Before They Boom,12/29/2022 4:30:22 PM
INCY,InnoCare tafasitamab combo gets approval in Hong Kong for blood cancer subtype,12/28/2022 10:30:16 AM
INCY,The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond,12/18/2022 2:04:41 PM
INCY,Cramer Says He's 'Always Liked' This Drug Company,12/16/2022 2:35:47 PM
INCY,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Sanofi (OtherSNYNF) and Abcam (ABCM)",12/15/2022 1:50:28 AM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Aerovate Therapeutics (AVTE),12/12/2022 11:50:11 AM
INCY,Syndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in Patients with Chronic Graft-Versus-Host Disease Published in the Journal of Clinical Oncology,12/5/2022 1:00:00 PM
INCY,RBC Capital Reaffirms Their Buy Rating on Incyte (INCY),11/17/2022 1:45:33 AM
INCY,"Incyte, Mirati team up for trial of combo therapy for solid tumors",11/7/2022 2:28:59 PM
INCY,7 Cash-Rich Stocks to Buy for Peace of Mind ,11/4/2022 6:22:18 PM
INCY,Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Avanos Medical (AVNS),11/3/2022 5:40:46 AM
INCY,Incyte (INCY) Receives a Hold from Morgan Stanley,11/2/2022 12:37:35 PM
INCY,Incyte rises 5% as company raises Jakafi net product revenues,11/1/2022 4:32:58 PM
INCY,Notable earnings before Tuesday's open,10/31/2022 3:21:29 PM
INCY,Incyte (INCY) Receives a Hold from Mizuho Securities,10/28/2022 8:15:21 AM
INCY,German biotech MorphoSys falls 10% after twin downgrades in Europe,10/24/2022 5:10:44 PM
INCY,MorphoSys lowers FY22 sales outlook for cancer drug Monjuvi on competition woes,10/21/2022 10:53:58 AM
INCY,Expert Ratings for Incyte,10/18/2022 10:05:12 PM
INCY,Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm',10/17/2022 7:59:39 PM
INCY,Knight's affiliate files for Brazilian approval of cancer drug tafasitamab,10/7/2022 11:25:53 AM
INCY,Mizuho Securities Remains a Hold on Incyte (INCY),10/3/2022 1:55:27 PM
INCY,MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings,9/29/2022 3:21:55 PM
INCY,Mizuho Securities Reaffirms Their Hold Rating on Incyte (INCY),9/27/2022 8:15:28 AM
INCY,"Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary",9/16/2022 12:47:03 AM
INCY,Incyte drug Pemazyre to treat rare cancer cholangiocarcinoma approved in Australia,9/15/2022 2:24:16 PM
INCY,Recap Of Friday's Biotech Catalysts - End Of the Day Summary,8/27/2022 1:52:44 AM
INCY,Incyte : FDA Oks Pemazyre For Treatment Of Myeloid/lymphoid Neoplasms With FGFR1 Rearrangement ,8/26/2022 4:16:14 PM
INCY,"Aclaris, Lilly ink patent license deal for Olumiant to treat alopecia areata",8/25/2022 1:03:42 PM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022",8/3/2022 4:38:05 PM
INCY,Incyte Q2 results beat on top and bottom lines as net income soars 27%; shares down 6%,8/2/2022 2:36:06 PM
INCY,Incyte Q2 2022 Earnings Preview,8/1/2022 5:04:31 PM
INCY,Biotech Investors: August's Key PDUFA Catalysts You Must Know,7/31/2022 3:21:24 PM
INCY,Expert Ratings for Incyte,7/28/2022 8:27:35 PM
INCY,"New Indication Approval For Incyte ""To Usher New Growth Avenue""",7/21/2022 7:03:18 PM
INCY,"The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings",7/19/2022 3:12:33 PM
INCY,"The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine",7/18/2022 3:19:50 PM
INCY,Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?,7/12/2022 7:33:16 PM
INCY,CTI BioPharma initiated at outperform at Cowen on potential for Vonjo for myelofibrosis,7/7/2022 4:54:50 PM
INCY,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,7/1/2022 11:26:23 AM
INCY,Biotech Stocks Facing FDA Decision In July 2022 ,6/28/2022 9:17:30 AM
INCY,7 Defensive Stocks to Buy for a Bear Market,6/27/2022 10:04:38 PM
INCY,"Pre-market Movers: REV, ASTL, VNRX, VORB, GGR… ",6/15/2022 12:55:15 PM
INCY,Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock,6/14/2022 8:09:00 PM
INCY,CTI BioPharma slips after disclosing data for myelofibrosis therapy,6/10/2022 12:31:56 PM
INCY,Lilly : CHMP Issues Positive Opinion For Olumiant For Severe Alopecia Areata Treatment ,5/20/2022 2:29:07 PM
INCY,Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted,5/13/2022 7:49:59 PM
INCY,Concert Pharma surges as U.S. patent office upholds key patent,5/12/2022 6:40:12 PM
INCY,"Eli Lilly, Incyte Announce FDA Approval Of OLUMIANT For Hospitalized Patients With COVID-19 ",5/11/2022 1:04:22 PM
INCY,"The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study",5/5/2022 2:43:28 PM
INCY,4 Analysts Have This to Say About Incyte,5/4/2022 9:21:24 PM
INCY,Incyte Q1 net income drops 17% as operating expenses soar,5/3/2022 4:31:58 PM
INCY,Global Cord Blood Enters Therapy Market Via Cellenkos Acquisition For Over $600M,5/2/2022 3:23:12 PM
INCY,3 Nasdaq Stocks to Buy Now for Growth,5/1/2022 10:15:52 AM
INCY,"Incyte, Maruho ink deal for exclusive commercialization of ruxolitinib cream in Japan",4/28/2022 8:12:05 PM
INCY,Why BriaCell Therapeutics Is Rising In Pre-market? ,4/13/2022 2:41:56 PM
INCY,AbbVie myelofibrosis candidate navitoclax shows improvement in mid-stage trial,4/12/2022 12:53:27 PM
INCY,"The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy",4/6/2022 2:02:15 PM
INCY,Nearly 40% of Adults with Alopecia Areata Taking OLUMIANT® 4-mg Saw at Least 80% Scalp Hair Coverage at 52 Weeks in Lilly's Pivotal Phase 3 Studies,3/26/2022 4:20:00 PM
INCY,"Novartis, Incyte Jakavi gets EMA panel nod for expanded use in graft-versus-host disease",3/25/2022 1:00:50 PM
INCY,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",3/23/2022 12:43:16 PM
INCY,MorphoSys rises after Swissmedic grants temporary approval to lymphoma treatment,3/22/2022 9:49:59 PM
INCY,Incyte's Opzelura review to treat vitiligo extended by 3 months by FDA,3/15/2022 9:44:21 AM
INCY,Insiders Buy More Than $80M Of 3 Stocks,3/11/2022 1:21:13 PM
INCY,Why Are Company Insiders Buying These 7 S&P 500 Stocks?,3/8/2022 9:07:28 PM
INCY,7 Insider Stocks to Buy as Execs Snap Them Up,2/18/2022 8:16:57 PM
INCY,Insiders Buy Around $112M Of 3 Stocks,2/15/2022 12:55:19 PM
INCY,Incyte slips despite revenue beat amid mixed outlook for newly launched product,2/9/2022 7:21:12 PM
INCY,"The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar",2/8/2022 2:29:54 PM
INCY,Incyte Q4 2021 Earnings Preview,2/7/2022 4:39:59 PM
INCY,Lilly To Discontinue Phase 3 Development Program For OLUMIANT In Lupus - Quick Facts ,1/28/2022 2:16:35 PM
INCY,"Incyte Pulls Parsaclisib US Application For Lymphoma Treatment, Bows Out Solid Tumor Program With Merus",1/26/2022 1:07:45 PM
INCY,Incyte withdraws NDA for lymphoma treatment parsaclisib,1/25/2022 9:51:54 PM
INCY,Innovent's Pemazyre for bile cancer gets approval in Hong Kong,1/24/2022 12:28:20 PM
INCY,Where Incyte Stands With Analysts,1/18/2022 8:27:47 PM
INCY,"Cramer Shares His Thoughts On Incyte, Corning And More",12/22/2021 1:12:06 PM
INCY,4 Stocks Insiders Are Buying,12/20/2021 10:04:05 AM
INCY,"Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022",12/19/2021 2:00:00 PM
INCY,Incyte receives Priority Review for Opzelura to treat vitiligo,12/14/2021 10:01:17 PM
INCY,New Nasdaq 100 tech stocks start week off with mild gains,12/13/2021 3:56:25 PM
INCY,Incyte Says Saw Survival Benefit For Patients With Refractory DLBCL In Tafasitamab  Combination Data ,12/11/2021 7:21:54 PM
INCY,7 CEOs That Ought to Follow Jack Dorsey Out the Door,12/10/2021 10:15:55 PM
INCY,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",12/6/2021 12:07:24 PM
INCY,AbbVie updates U.S. labeling info for RINVOQ in rheumatoid arthritis,12/3/2021 9:43:36 PM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021",11/19/2021 4:08:55 PM
INCY,"OLUMIANT® Long-Term Safety Profile Established Up to 9.3 Years in Integrated Analysis of More Than 3,700 Patients with Rheumatoid Arthritis",11/9/2021 2:30:00 PM
INCY,Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies,11/4/2021 3:07:00 PM
INCY,Incyte shares fall despite Jakafi powered Q3 earnings beat,11/2/2021 2:01:50 PM
INCY,Incyte Q3 2021 Earnings Preview,11/1/2021 4:37:58 PM
INCY,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
INCY,EMA validates Incyte's ruxolitinib MAA as potential treatment of non-segmental vitiligo,10/28/2021 11:57:36 AM
INCY,"The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results",10/7/2021 2:23:53 PM
INCY,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",10/6/2021 1:33:33 PM
INCY,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",10/5/2021 2:01:45 PM
INCY,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,10/1/2021 8:17:08 PM
INCY,"Lilly, Incyte Present Detailed Results From OLUMIANT BRAVE-AA1, BRAVE-AA2 Trials In Alopecia Areata ",9/30/2021 12:40:08 PM
INCY,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",9/28/2021 2:18:52 PM
INCY,"Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate",9/27/2021 3:23:12 PM
INCY,Expert Ratings For Incyte,9/23/2021 6:41:43 PM
INCY,"The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs",9/22/2021 1:45:28 PM
INCY,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",9/21/2021 2:20:50 PM
INCY,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",9/19/2021 3:46:51 PM
INCY,"Catalyst watch for next week: FedEx and Nike report, FOMC watch, IPO blitz",9/17/2021 7:00:20 PM
INCY,"FDA action dates, catalysts, and other events for pharma/biotech in September",9/2/2021 7:42:44 PM
INCY,Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates,8/31/2021 8:00:15 PM
INCY,Biotech Stocks Facing FDA Decision In September 2021 ,8/30/2021 8:43:24 AM
INCY,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",8/27/2021 1:35:25 PM
INCY,Incyte Reports Conditional Approval Of Minjuvi In Canada For Patients With DLBCL ,8/24/2021 2:44:10 PM
INCY,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",8/17/2021 2:28:53 PM
INCY,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",8/13/2021 1:43:02 PM
INCY,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
INCY,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
INCY,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",8/10/2021 1:55:36 PM
INCY,Incyte Corporation Q2 adjusted earnings Beat Estimates,8/3/2021 1:32:33 PM
INCY,Notable earnings before Tuesday's open,8/2/2021 2:02:49 PM
INCY,Incyte earnings: here's what to expect,8/1/2021 3:01:51 PM
INCY,Lilly : FDA Broadens Emergency Use Of Baricitinib In Patients Hospitalized With COVID-19 ,7/29/2021 3:45:21 PM
INCY,7 Cheap Value Stocks to Buy for August 2021,7/27/2021 6:23:20 PM
INCY,Incyte : FDA Issues Complete Response Letter For Retifanlimab ,7/24/2021 5:15:09 AM
INCY,"NRXP, PDD, ACOR and IPA among after-hours movers",7/23/2021 9:40:34 PM
INCY,Benchmark Upgrades Incyte After Stock Selloff,7/20/2021 9:28:19 PM
INCY,Lilly : FDA Delays Review Of Baricitinib SNDA On Atopic Dermatitis ,7/16/2021 4:33:50 PM
INCY,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",7/15/2021 2:07:56 PM
INCY,BriaCell/Incyte opens enrollment for Phase I/IIa combo study in breast cancer,7/14/2021 11:30:52 AM
INCY,China's NMPA accepts Innovent's pemigatinib NDA for review,7/9/2021 11:47:28 AM
INCY,Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates,7/1/2021 11:07:05 PM
INCY,Lilly and Regeneron monoclonal antibodies among preferred therapies in EU against COVID-19,6/29/2021 3:54:15 PM
INCY,"Incyte, MorphoSys Get Positive CHMP Opinion For Tafasitamab In Combination With Lenalidomide ",6/25/2021 2:04:26 PM
INCY,FDA Panel Defers Incyte's Anal Cancer Drug ,6/24/2021 9:55:57 PM
INCY,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs",6/20/2021 4:04:37 PM
INCY,Seeking Alpha Catalyst Watch,6/18/2021 7:30:24 PM
INCY,Incyte : FDA Extends NDA Review Period For Ruxolitinib In Atopic Dermatitis ,6/11/2021 2:19:35 PM
INCY,Incyte Says FDA Extends Review Period For Ruxolitinib SNDA - Quick Facts ,6/8/2021 2:13:31 PM
INCY,Incyte and MorphoSys present new three-year data for blood cancer therapy,6/4/2021 6:49:16 PM
INCY,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,6/1/2021 11:31:09 PM
INCY,Incyte Says Phase 3 TRuE-V Trial Met Primary And Key Secondary Endpoints - Quick Facts ,5/17/2021 2:12:50 PM
INCY,"The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron",5/12/2021 2:57:17 PM
INCY,Incyte and Morphosys dose first patient in late-stage lymphoma study,5/11/2021 8:07:41 PM
INCY,"The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data",5/4/2021 2:10:21 PM
INCY,Notable earnings before Tuesday's open,5/3/2021 5:04:25 PM
INCY,What Wall Street expects from Incyte's earnings,5/2/2021 3:01:32 PM
INCY,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
INCY,Incyte-partnered anti-PD-1 therapy wins FDA’s orphan drug designation for liver cancer,4/29/2021 6:01:35 PM
INCY,Incyte : Olumiant Shows Improvements In Severity And Extent Of Atopic Dermatitis ,4/23/2021 4:44:02 PM
INCY,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",4/20/2021 2:06:58 PM
INCY,Incyte and Morphosys dose first patient in late-stage lymphoma study,4/19/2021 8:11:47 PM
INCY,Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial,4/16/2021 8:47:11 PM
INCY,Merck hurt by another setback in its battle against COVID-19,4/15/2021 5:39:05 PM
INCY,Seeking Alpha Catalyst Watch,4/9/2021 5:30:00 PM
INCY,"The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data",4/8/2021 2:14:49 PM
INCY,"The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award",4/7/2021 1:57:58 PM
INCY,"FDA extends review period for Eli Lilly, Incyte's baricitinib atopic dermatitis sNDA",4/6/2021 8:39:09 PM
INCY,Incyte's Pemazyre wins European Commission approval to treat rare form of cancer,3/29/2021 4:19:14 PM
INCY,Incyte's Pemazyre OK'd in Japan for bile duct cancer,3/23/2021 10:40:48 AM
INCY,Incyte COVID-19 candidate misses primary endpoint in late-stage study (updated),3/18/2021 8:37:55 PM
INCY,Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs,3/12/2021 6:04:49 PM
INCY,"Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment- Quick Facts ",3/3/2021 1:34:53 PM
INCY,7 Beaten Down Stocks With Significant Insider Buying,3/1/2021 1:20:45 PM
INCY,"The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More",2/28/2021 2:36:40 PM
INCY,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",2/26/2021 2:16:52 PM
INCY,FDA accepts Incyte's ruxolitinib NDA with Priority Review,2/19/2021 2:26:02 PM
INCY,"Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2021",2/10/2021 4:05:07 PM
INCY,"The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement",2/9/2021 2:10:28 PM
INCY,Notable earnings before Tuesday's open,2/8/2021 5:05:52 PM
INCY,Here's what Wall Street expects from Incyte's earnings report,2/7/2021 3:01:47 PM
INCY,"The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight",2/6/2021 6:42:05 PM
INCY,Incyte's pemigatinib gets positive recommendation from CHMP,1/29/2021 8:06:16 PM
INCY,Incyte's retifanlimab wins FDA's Priority Review status,1/21/2021 9:37:35 PM
INCY,"The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations",1/13/2021 1:25:38 PM
INCY,Incyte/MorphoSys' tafasitamab Canada application accepted for review,1/12/2021 9:15:06 PM
INCY,"Benzinga's Top Upgrades, Downgrades For January 7, 2021",1/7/2021 6:10:07 PM
INCY,MorphoSys : Swiss Regulator Accepts Marketing Authorization Application For Tafasitamab ,1/5/2021 8:45:37 AM
INCY,Why These Health Care Stocks Are Moving Today,12/30/2020 8:06:40 PM
INCY,Merus rises 4% on Incyte stake disclosure,12/29/2020 10:51:37 AM
INCY,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",12/26/2020 3:15:52 PM
INCY,7 Biotech Stocks To Buy Beyond Covid Vaccine Plays,12/14/2020 6:37:56 PM
INCY,Eli Lilly/Incyte announce peer-reviewed publication of Baricitinib/remdesivir trial data,12/11/2020 7:45:03 PM
INCY,Eyes on Constellation Pharma after ASH conference presentation on CPI-0610 for myelofibrosis,12/6/2020 11:14:39 PM
INCY,IMV T cell therapy shows positive action in treatment-resistant ovarian cancer; shares up 5%,12/3/2020 12:48:08 PM
INCY,Kinnate Biopharma increases IPO size by 25% to $213M,12/2/2020 1:49:15 PM
INCY,MacroGenics secures $25M milestone payment from Incyte,11/30/2020 1:53:22 PM
INCY,"AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B ",11/20/2020 7:46:37 AM
INCY,"Xencor, MorphoSys And Incyte Ink Collaboration Deal ",11/11/2020 11:11:41 PM
INCY,"Incyte Q3 Adj. Earnings, Revenue Miss Estimates - Quick Facts ",11/5/2020 3:27:24 PM
INCY,Incyte Q3 2020 Earnings Preview,11/4/2020 6:12:11 PM
INCY,"Lilly, Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia Areata ",10/30/2020 12:26:12 PM
INCY,Incyte's Atopic Dermatitis Studies Of Ruxolitinib Cream Show Clinically Meaningful Improvements ,10/29/2020 4:21:14 PM
INCY,Health Canada accepts Incyte's pemigatinib application for bile duct cancer,10/26/2020 2:02:16 PM
INCY,Lilly/Incyte's baricitinib shows additional benefit in hospitalized COVID-19 patients,10/16/2020 8:03:31 PM
INCY,Lilly's baricitinib shows incremental benefit in hospitalized COVID-19 patients,10/8/2020 4:20:17 PM
INCY,"Lilly, Incyte: CHMP Adopts Positive Opinion For Baricitinib In Treatment Of Atopic Dermatitis ",9/18/2020 2:04:17 PM
INCY,"Lilly, Incyte Announce Initial Data From Adaptive COVID-19 Treatment Trial - Quick Facts ",9/14/2020 1:19:20 PM
INCY,Incyte Q2 Profit Tops Estimates - Quick Facts ,8/4/2020 1:57:23 PM
INCY,Incyte earnings preview: what to expect,8/3/2020 3:01:57 PM
INCY,5 High-Yield Drug Stocks That Are Undervalued With Great Upside,7/24/2020 6:06:35 PM
INCY,Incyte Receives Approval For Tabrecta In Japan For Patients With Advanced NSCLC With METex14 ,6/29/2020 1:28:58 PM
INCY,Lilly Starts Phase 3 Clinical Trial With Baricitinib For Hospitalized COVID-19 Patients ,6/15/2020 1:00:05 PM
INCY,MorphoSys Announce Validation Of EMA Application For Tafasitamab ,5/21/2020 3:20:25 AM
INCY,Morphosys up 3% on long-term tafasitamab data in blood cancer,5/14/2020 4:04:42 PM
INCY,"Incyte Slips To Loss In Q1, Despite Higher Revenues - Quick Facts ",5/5/2020 1:49:57 PM
INCY,Incyte is about to announce earnings — here's what Wall Street expects,5/4/2020 3:01:31 PM
INCY,7 Beautiful Biotech Stocks to Buy Here,4/24/2020 3:41:09 PM
INCY,FDA Approves First Targeted Treatment For Bile Duct Cancer ,4/20/2020 3:14:03 PM
INCY,FDA OKs Incyte's pemigatinib for type of bile duct cancer,4/18/2020 2:40:58 PM
INCY,Incyte launches pivotal study of Jakafi for COVID-19 complication,4/17/2020 7:56:28 PM
INCY,RemeGen candidate Fast Track'd for lupus,4/15/2020 3:13:45 PM
INCY,Incyte details late-stage data on ruxolitinib cream for atopic dermatitis,4/5/2020 6:55:44 PM
INCY,Incyte to test Jakafi in COVID-19 patients,4/3/2020 11:17:29 AM
INCY,Oppenheimer sees 26% downside in Intuitive Surgical in premarket action,4/1/2020 11:51:39 AM
INCY,FDA grants BTD tag to baricitinib for alopecia areata,3/16/2020 11:10:24 AM
INCY,"MorphoSys, Incyte Receive Antitrust Clearance For Collaboration On Tafasitamab ",3/4/2020 3:03:44 AM
INCY,Incyte's ruxolitinib successful in second late-stage dermatitis study,2/19/2020 12:54:39 PM
INCY,Incyte Q4 Adj. Operating Income Rises; Jakafi Revenues Up 23% - Quick Facts ,2/13/2020 1:31:30 PM
INCY,Incyte is about to announce its earnings — here's what Wall Street expects,2/12/2020 3:03:08 PM
INCY,"Eli Lilly, Incyte: Baricitinib Meets Primary Endpoint In BREEZE-AD5 Study ",1/30/2020 12:47:34 PM
INCY,Lilly : Study Meets Primary Endpoint Of 75% Improvement Of Skin Inflammation ,1/27/2020 12:57:19 PM
INCY,"MorphoSys, Incyte Agree To Co-commercialize Tafasitamab In The U.S. ",1/13/2020 7:54:23 AM
INCY,Stock Market Today: Is the Rally Ruined?; Tesla’s New Record,1/3/2020 9:26:51 PM
INCY,Why Longer-Term Investors Should Buy Amarin Stock on Weakness,12/19/2019 10:16:39 AM
INCY,Are These Biotech Companies Buyout Candidates? Deal Or No Deal? ,12/14/2019 9:14:45 AM
INCY,7 Exciting Biotech Stocks to Buy Now,12/2/2019 7:57:21 PM
INCY,Incyte Q3 Profit Surges; Raises FY19 Jakafi Revenue Outlook - Quick Facts ,10/29/2019 12:54:33 PM
INCY,10 Great Biotech Stocks to Buy in Q4,10/7/2019 4:17:20 PM
INCY,10 Stocks to Buy for September,8/29/2019 6:30:32 PM
INCY,The 10 Best Stocks to Invest in for August,7/30/2019 5:50:33 PM
INCY,Incyte earnings: here's what to expect,7/29/2019 3:02:47 PM
INCY,4 Biotech Stocks Sliding Lower,7/26/2019 4:04:19 PM
INCY,"Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?",6/26/2019 8:46:45 PM
INCY,Nasdaq Today: Maintaining Altitude Amid Uncertainty,6/21/2019 8:30:47 PM
INCY,7 Hot Stocks to Buy for a Seemingly Sleepy Summer,6/18/2019 7:03:57 PM
INCY,7 Top-Rated Biotech Stocks to Invest In Today,6/14/2019 6:59:58 PM
INCY,Incyte To No Longer Participate In Co-funding Of Development Of Baricitinib ,4/30/2019 2:07:16 PM
INCY,What Wall Street expects from Incyte's earnings,4/29/2019 3:02:37 PM
INCY,Biotech Stocks Facing FDA Decision In May 2019 ,4/26/2019 9:15:22 AM
INCY,"Beware Of Fake Leukemia Drug Iclusig, Warns WHO ",2/21/2019 11:54:23 AM
INCY,Incyte earnings preview: what Wall Street is expecting,2/13/2019 3:02:41 PM
INCY,Lilly : Baricitinib Meets Primary Endpoint In BREEZE-AD1 And BREEZE-AD2 ,2/4/2019 12:52:11 PM
INCY,Biotech Stocks Facing FDA Decision In February ,1/30/2019 8:19:45 AM
INCY,Incyte Names Christiana Stamoulis CFO - Quick Facts ,1/3/2019 1:08:45 PM
INCY,"Innovent, Incyte In Deal For Three Clinical-stage Product Candidates In China ",12/17/2018 1:57:00 AM
INCY,Eli Lilly : FDA Grants Fast Track Designation To Baricitinib Development Program ,12/13/2018 12:58:22 PM
INCY,Incyte Corporation Q3 adjusted earnings Miss Estimates,10/30/2018 12:51:55 PM
INCY,What Wall Street expects from Incyte's earnings,10/29/2018 3:02:58 PM
INCY,Incyte: FDA Grants Priority Review For Ruxolitinib ,10/25/2018 2:56:23 PM
INCY,"FDA Extends Date On BMY's SBLA, Genmab Meets Phase 3 Goals, NCNA, LPTX On Watch ",10/22/2018 5:43:33 AM
INCY,Incyte Announces Positive Interim Data From Phase 2 Trial Of Pemigatinib ,10/21/2018 4:06:45 PM
INCY,"Week Ahead In Pharmaceuticals: 5 Stocks To Watch (KNSA, INCY, ANAB...) ",9/9/2018 3:32:32 AM
INCY,Incyte CFO David Gryska To Retire At 2018- End; Search Underway For New CFO ,9/7/2018 7:03:04 AM
INCY,Incyte earnings preview: what Wall Street is expecting,7/30/2018 3:02:45 PM
INCY,Incyte: REACH1 Pivotal Trial With Ruxolitinib Meets Primary Endpoint ,6/21/2018 2:26:02 PM
INCY,"Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology",6/11/2018 12:45:00 PM
INCY,"Lifshitz & Miller LLP Announces Investigation of ARMO BioSciences, Inc., Financial Engines, Inc., Globalstar, Inc., Gridsum Holding Inc., InnerWorkings, Inc., Incyte Corporation, PPG Industries, Inc.",6/6/2018 12:02:00 AM
INCY,"FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early ",6/4/2018 6:46:25 AM
INCY,FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis,6/1/2018 6:04:00 PM
INCY,BRIEF-Incyte Reports Q1 Loss Of $0.19 Per Share,5/1/2018 1:27:33 PM
INCY,"PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA ",4/24/2018 8:46:50 AM
INCY,UPDATE 1-FDA panel backs lower dose of Lilly-Incyte arthritis drug over higher,4/23/2018 11:25:53 PM
INCY,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)",4/20/2018 4:54:00 PM
INCY,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY,4/19/2018 11:27:00 PM
INCY,"A cancer drugmaker just failed a key trial and its stock is crashing (INCY, MRK)",4/6/2018 3:21:06 PM
INCY,Biotech Stocks Facing FDA Decision In April ,3/28/2018 1:58:32 PM
INCY,EARNINGS SUMMARY: Details of Incyte Corporation Q4 Earnings Report,2/15/2018 1:05:32 PM
INCY,Vancouver Island 2018 Property Assessment Notices in the Mail,1/2/2018 6:00:00 PM
INCY,"FACBOX-Corporate alternative minimum tax threat hits pharma, tech (BA, VRTX, INCY, REGN, CDNS, CELG, ADSK)",12/6/2017 9:52:03 PM
INCY,BRIEF-Immunovaccine announces positive clinical data from its collaborative combination immunotherapy trial in advanced ovarian cancer (INCY),12/5/2017 2:12:06 PM
INCY,Incyte Starts Clinical Trial Of Ruxolitinib For Essential Thrombocythemia ,11/15/2017 1:47:32 PM
INCY,"Lilly, Incyte: Baricitinib Shows Greater Improvements In Pain Control In RA ",11/6/2017 5:38:55 AM
INCY,ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo,11/5/2017 3:00:00 PM
INCY,Incyte Corporation Announces 2% Retreat In Q3 Earnings,10/31/2017 12:24:43 PM
INCY,BRIEF-Incyte Corp names new member to its board of directors (INCY),10/30/2017 10:57:07 PM
INCY,BRIEF-Concert Pharma Says PTAB denies Incyte petition challenging CTP-543 patent (INCY),10/19/2017 7:07:03 PM
INCY,"Indigenous groups, science community, marine industry, and government partners make progress in protecting endangered killer whale population",10/14/2017 3:00:00 AM
INCY,"MDA Completes Acquisition of DigitalGlobe, Creates Industry Leader in Satellite Systems, Earth Imagery, Geospatial Solutions and Analytics",10/5/2017 2:54:00 PM
INCY,"UPDATE 1-Lilly/Incyte pill beats placebo in mid-stage eczema trial (LLY, INCY, REGN, SAN)",9/14/2017 8:52:15 PM
INCY,"BRIEF-Incyte announces pricing of public offering of 4,945,000 shares (INCY)",9/8/2017 3:07:04 PM
INCY,Landmark M&A Deals Continue to Shape Big Pharma,9/6/2017 2:30:00 PM
INCY,"AstraZeneca aims to offset drug setback at big cancer congress (AZN, LLY, PFE, BMY, MRK, INCY)",8/31/2017 2:52:03 PM
INCY,Lilly To Resubmit NDA For Baricitinib To FDA Before End Of January 2018 ,8/30/2017 1:02:01 PM
INCY,"Technical Snapshots for These Biotech Stocks -- ImmunoGen, Incyte, Infinity Pharma, and Jazz Pharma",8/11/2017 12:15:00 PM
INCY,EARNINGS SUMMARY: Details of Incyte Corporation Q2 Earnings Report,8/1/2017 1:15:18 PM
INCY,"Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX ",7/26/2017 8:55:22 AM
INCY,"BRIEF-Lilly and Incyte provide update on baricitinib (INCY, LLY)",7/25/2017 12:36:07 PM
INCY,"AEZS Gets Down To Serious Work, APVO Surges, FDA Tentative Nod For MRK ",7/21/2017 7:22:01 AM
INCY,BRIEF-Incyte says first patient treated in Phase 3 clinical trial of itacitinib (INCY),7/20/2017 1:54:03 PM
INCY,"BRIEF-Incyte says Japan Ministry of Health, Labor And Welfare grants marketing approval for Olumiant (INCY, LLY)",7/3/2017 2:16:04 PM
INCY,New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017,6/16/2017 10:15:00 AM
INCY,Lilly to Present New Data on Olumiant® (baricitinib) in Rheumatoid Arthritis and Taltz® (ixekizumab) in Psoriatic Arthritis at the Annual European Congress of Rheumatology (EULAR 2017),6/14/2017 12:01:00 AM
INCY,"UPDATE 1-AbbVie's rheumatoid arthritis drug succeeds in late-stage trial (AMGN, PFE, LLY, INCY)",6/7/2017 2:52:06 PM
INCY,"BRIEF-Incyte says epacadostat, Bristol-Myers' Opdivo combo data positive in head and neck cancer patients (INCY, BMY)",6/5/2017 1:48:05 PM
INCY,A $25 billion biotech's stock is popping on its promising cancer data (INCY),5/18/2017 4:36:23 PM
INCY,"Merck, Incyte immunotherapy combination effective in lung cancer study (MRK, INCY)",5/17/2017 11:16:05 PM
INCY,"Technical Reports on Biotech Stocks -- Celsion, Incyte, ImmunoGen, and Catabasis Pharma",5/11/2017 12:10:00 PM
INCY,EARNINGS SUMMARY: Details of Incyte Corporation Q1 Earnings Report,5/4/2017 3:29:17 PM
INCY,"Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc.",4/29/2017 1:17:00 AM
INCY,"UPDATE 1-Eli Lilly's profit beats on demand for newer drugs (LLY, INCY)",4/25/2017 1:11:08 PM
INCY,"EMA panel recommends nod for Sanofi, Regeneron's arthritis drug (SAN, REGN, JNJ, LLY, INCY)",4/21/2017 9:51:09 PM
INCY,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)",4/20/2017 4:00:00 PM
INCY,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY,4/19/2017 5:38:00 PM
INCY,"Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... ",4/18/2017 3:27:48 AM
INCY,"US STOCKS-Wall St rallies in low volume led by banks, tech (NFLX, AMZN, BA, INCY, LLY)",4/17/2017 10:45:05 PM
INCY,"U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant (LLY, INCY, PFE)",4/14/2017 6:05:04 PM
INCY,Company Spotlight: Incyte ,4/13/2017 4:55:52 PM
INCY,"Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise ",4/3/2017 6:05:53 AM
INCY,"Incyte, Merck Give Further Details On Epacadostat - KEYTRUDA Clinical Program ",3/31/2017 1:41:14 PM
INCY,Biotech Stocks Facing FDA Decision In April ,3/24/2017 11:33:55 AM
INCY,"How These Biotech Stocks are Faring? -- Geron, Incyte, Illumina, and Bellerophon Therapeutics",3/3/2017 1:15:00 PM
INCY,"BRIEF-Incyte to replace Spectra Energy in S&P 500 (INCY, SE, CBOE, PBI)",2/24/2017 12:24:14 AM
INCY,"Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400",2/23/2017 11:57:00 PM
INCY,BRIEF-Incyte Corp says entered into letter agreement with certain entities affiliated with Julian Baker - SEC filing (INCY),2/21/2017 2:46:12 PM
INCY,"BRIEF-Eli Lilly says additional results from pivotal ra-beam study published in New England Journal of Medicine (INCY, LLY)",2/16/2017 12:12:11 AM
INCY,BRIEF-Incyte reports Q4 earnings per share $0.05 (INCY),2/14/2017 1:26:10 PM
INCY,"BRIEF-European Commission approves once-daily olumiant tablets for treatment of rheumatoid arthritis (INCY, LLY)",2/13/2017 10:56:10 PM
INCY,"BRIEF-Immunovaccine says Princess Margaret Cancer Centre to conduct Phase 2 clinical trial to evaluate use of co, Merck's combination of immunotherapies (MRK, INCY)",2/6/2017 2:14:08 PM
INCY,BRIEF-Incyte and Calithera Biosciences announce global collaboration  to develop and commercialize CB-1158 (INCY),1/30/2017 1:28:11 PM
INCY,BRIEF-Merus announces closing of global strategic research collaboration with Incyte (INCY),1/23/2017 10:40:05 PM
INCY,"BRIEF-Incyte and Merck to advance clinical development program investigating the combination of Epacadostat with Keytruda (INCY, MRK)",1/9/2017 2:34:05 PM
INCY,BRIEF-Incyte announces first patient treated in clinical trial program in graft-versus-host disease (INCY),12/30/2016 10:36:03 PM
INCY,"BRIEF-Incyte Corp , Eli Lilly amended license, development and commercialization agreement, entered into as of December 18, 2009 (INCY, LLY)",12/16/2016 10:44:02 PM
INCY,"RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",12/6/2016 2:02:03 PM
INCY,"BRIEF-Agenus to start the phase 1/2 clinical trial of anti-OX40 (AGEN, INCY)",11/30/2016 5:10:03 PM
INCY,"BRIEF-Baricitinib demonstrates early response compared to placebo (INCY, LLY)",11/14/2016 7:00:18 PM
INCY,BRIEF-Incyte Corp provides additional Phase 1 Data from ECHO-202 trial (INCY),10/7/2016 3:10:21 PM
INCY,BRIEF-Incyte corp - Epacadostat in combination with Pembrolizumab was well-tolerated (INCY),9/28/2016 3:10:26 PM
